SHAHEEN AHMAD: Open Payments
NPI 1205447406 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,165 in 22 payments from 7 companies in 2025. Trend: 2023 $1,011 · 2024 $657 · 2025 $1,165
Food & beverage: $1,165
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 9 | $288 |
| Neurocrine BioSciences, Inc. | 2 | $261 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $146 |
| ABBVIE INC. | 7 | $139 |
| Otsuka America Pharmaceutical, Inc. | 1 | $120 |
| Alkermes, Inc. | 1 | $115 |
| Janssen Pharmaceuticals, Inc | 1 | $95 |
Products named: COBENFY, INGREZZA, CAPLYTA, VRAYLAR, REXULTI, LYBALVI, SPRAVATO.
Industry payments across NV — which companies pay providers there.
